alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



Exhibit 12.1
 
 UGI UTILITIES INC.
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES  EXHIBIT 12.1
(Thousands of dollars)
 ThreeMonthsEndedDecember 31,
    
    Year Ended September 30,2007
    
    
    2007
    
    
    2006
    
    
    2005
    
    
    2004
    
    
    2003Earnings:Earnings before income taxes
    
    $
    47,709
    
    
    $
    122,766
    
    
    $
    80,544
    
    
    $
    84,953
    
    
    $
    83,098
    
    
    $
    100,212Interest expense
    
    
    10,785
    
    
    
    42,327
    
    
    
    24,102
    
    
    
    18,079
    
    
    
    17,698
    
    
    
    17,412Amortization of debt discount and expense
    
    
    115
    
    
    
    462
    
    
    
    243
    
    
    
    247
    
    
    
    233
    
    
    
    244Estimated interest component of rental expense
    
    
    456
    
    
    
    1,506
    
    
    
    1,675
    
    
    
    1,568
    
    
    
    1,477
    
    
    
    1,434$
    59,065
    
    
    $
    167,061
    
    
    $
    106,564
    
    
    $
    104,847
    
    
    $
    102,506
    
    
    $
    119,302Fixed Charges:Interest expense
    
    $
    10,785
    
    
    $
    42,327
    
    
    $
    24,102
    
    
    $
    18,079
    
    
    $
    17,698
    
    
    $
    17,412Amortization of debt discount and expense
    
    
    115
    
    
    
    462
    
    
    
    243
    
    
    
    247
    
    
    
    233
    
    
    
    244Allowance for funds used during
construction (capitalized interest)
    
    
    51
    
    
    
    179
    
    
    
    85
    
    
    
    22
    
    
    
    11
    
    
    
    7Estimated interest component of rental expense
    
    
    456
    
    
    
    1,506
    
    
    
    1,675
    
    
    
    1,568
    
    
    
    1,477
    
    
    
    1,434$
    11,407
    
    
    $
    44,474
    
    
    $
    26,105
    
    
    $
    19,916
    
    
    $
    19,419
    
    
    $
    19,097Ratio of earnings to fixed charges
    
    
    5.18
    
    
    
    3.76
    
    
    
    4.08
    
    
    
    5.26
    
    
    
    5.28
    
    
    
    6.25
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED CONDENSED FINANCIAL STATEMENTS AS OF MARCH 31, 1997 AND FOR
THE THREE MONTHS THEN ENDED AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                          19,019
<SECURITIES>                                         0
<RECEIVABLES>                                  104,436
<ALLOWANCES>                                         0
<INVENTORY>                                    704,502
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 971,680
<CURRENT-LIABILITIES>                                0
<BONDS>                                        360,386
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           116
<OTHER-SE>                                     383,784
<TOTAL-LIABILITY-AND-EQUITY>                   971,680
<SALES>                                              0
<TOTAL-REVENUES>                               316,033
<CGS>                                          255,580
<TOTAL-COSTS>                                  291,744
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               8,189
<INCOME-PRETAX>                                 16,100
<INCOME-TAX>                                     5,957
<INCOME-CONTINUING>                             10,143
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    10,143
<EPS-PRIMARY>                                      .84
<EPS-DILUTED>                                      .75
        

</TABLE>
EXHIBIT 32.2
 
 
 CERTIFICATION OF CHIEF FINANCIAL OFFICER
 PURSUANT TO 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO SECTION 906 OF THE
 SARBANES-OXLEY ACT OF 2002
 
 
 In connection with the quarterly report of United-Guardian, Inc. (the "Company") on Form 10-Q for the three- and nine-month periods ended September 30, 2009, as filed with the Securities and Exchange Commission (the "Report"), I, Robert S. Rubinger, Chief Financial Officer of the Company, hereby certify, pursuant
to 18 U.S.C.  Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
 (i) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 (ii) The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of the dates presented and results of operations of the Company for the periods presented.
   Date:  November 12, 2009
By:
/s/ Robert S. RubingerRobert S. Rubinger
# Official Journal L 383/2020

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 383 |
| | |
| English edition | Legislation | Volume 6316 November 2020 |

ISSN 1977-0677

Official Journal

of the European Union

L 383

English edition

Legislation

Volume 6316 November 2020

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | INTERNATIONAL AGREEMENTS |
| | * | Council Decision (EU) 2020/1704 of 23 October 2020 on the signing, on behalf of the Union, and provisional application of the Agreement in the form of an Exchange of Letters between the European Union and the Islamic Republic of Mauritania on an extension to the Protocol setting out the fishing opportunities and financial contribution provided for in the Fisheries Partnership Agreement between the European Community and the Islamic Republic of Mauritania, expiring on 15 November 2020 | 1 |
| | * | Agreement in the form of an Exchange of Letters between the European Union and the Islamic Republic of Mauritania on an extension to the Protocol setting out the fishing opportunities and financial contribution provided for in the Fisheries Partnership Agreement between the European Community and the Islamic Republic of Mauritania, expiring on 15 november 2020 | 3 |

Contents

II   Non-legislative acts

page

INTERNATIONAL AGREEMENTS

*

Council Decision (EU) 2020/1704 of 23 October 2020 on the signing, on behalf of the Union, and provisional application of the Agreement in the form of an Exchange of Letters between the European Union and the Islamic Republic of Mauritania on an extension to the Protocol setting out the fishing opportunities and financial contribution provided for in the Fisheries Partnership Agreement between the European Community and the Islamic Republic of Mauritania, expiring on 15 November 2020

1

*

Agreement in the form of an Exchange of Letters between the European Union and the Islamic Republic of Mauritania on an extension to the Protocol setting out the fishing opportunities and financial contribution provided for in the Fisheries Partnership Agreement between the European Community and the Islamic Republic of Mauritania, expiring on 15 november 2020

3

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
# C_2016419EN.01003901.xml

| 14.11.2016 | EN | Official Journal of the European Union | C 419/39 |
| --- | --- | --- | --- |

14.11.2016

EN

Official Journal of the European Union

C 419/39

---

Judgment of the General Court of 29 September 2016 — Universal Protein Supplements v EUIPO (Representation of a body builder)

(Case T-335/15) (1)

1

((EU trade mark - Application for registration of an EU figurative mark representing a body-builder - Absolute grounds for refusal - Descriptive character - Article 7(1)(c) of Regulation (EC) No 207/2009))

(2016/C 419/49)

Language of the case: English

Parties

Parties

Applicant: Universal Protein Supplements Corp. (New Brunswick, New Jersey, United States) (represented by: S. Malynicz QC)

Applicant:

Defendant: European Union Intellectual Property Office (represented by: initially by H. O’Neill, and subsequently by A. Folliard-Monguiral, acting as Agents)

Defendant:

Re:

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 6 March 2015 (Case R 2958/2014-5) concerning an application for registration of a figurative sign representing a body-builder as an EU trade mark.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Universal Protein Supplements Corp. to pay the costs. |
| --- | --- |

2.

Orders Universal Protein Supplements Corp. to pay the costs.

---

(1)  OJ C 279, 24.8.2015.

1

---
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 487 Agreed to Senate (ATS)]

109th CONGRESS
  2d Session
S. RES. 487

  Expressing the sense of the Senate with regard to the importance of 
 Women's Health Week, which promotes awareness of diseases that affect 
women and which encourages women to take preventive measures to ensure 
                              good health.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 22, 2006

   Mr. Feingold (for himself and Ms. Snowe) submitted the following 
             resolution; which was considered and agreed to

_______________________________________________________________________

                               RESOLUTION

 
  Expressing the sense of the Senate with regard to the importance of 
 Women's Health Week, which promotes awareness of diseases that affect 
women and which encourages women to take preventive measures to ensure 
                              good health.

Whereas women of all backgrounds have the power to greatly reduce their risk of 
        common diseases through preventive measures such as a healthy lifestyle 
        and frequent medical screenings;
Whereas significant disparities exist in the prevalence of disease among women 
        of different backgrounds, including women with disabilities, African 
        American women, Asian/Pacific Islander women, Latinas, and American 
        Indian/Alaska Native women;
Whereas since healthy habits should begin at a young age, and preventive care 
        saves Federal dollars designated to health care, it is important to 
        raise awareness among women and girls of key female health issues;
Whereas National Women's Health Week begins on Mother's Day annually and 
        celebrates the efforts of national and community organizations working 
        with partners and volunteers to improve awareness of key women's health 
        issues; and
Whereas in 2006, the week of May 14 through May 20, is dedicated as the National 
        Women's Health Week: Now, therefore, be it
    Resolved, That the Senate--
            (1) recognizes the importance of preventing diseases that 
        commonly affect women;
            (2) calls on the people of the United States to use Women's 
        Health Week as an opportunity to learn about health issues that 
        face women;
            (3) calls on the women of the United States to observe 
        National Women's Check-Up Day on Monday, May 15, 2006, by 
        receiving preventive screenings from their health care 
        providers; and
            (4) recognizes the importance of federally funded programs 
        that provide research and collect data on common diseases in 
        women and highlight racial disparities in the rates of these 
        diseases.
                                 <all>
```
# C_2015190EN.01000301.xml

| 8.6.2015 | EN | Official Journal of the European Union | C 190/3 |
| --- | --- | --- | --- |

8.6.2015

EN

Official Journal of the European Union

C 190/3

---

Appeal brought on 23 March 2015 by Teva Pharma BV and Teva Pharmaceuticals Europe BV against the judgment of the General Court (Sixth Chamber) delivered on 22 January 2015 in Case T-140/12: Teva Pharma BV and Teva Pharmaceuticals Europe BV v European Medecines Agency (EMA)

(Case C-138/15 P)

(2015/C 190/03)

Language of the case: English

Parties

Appellants: Teva Pharma BV and Teva Pharmaceuticals Europe BV (represented by: G. Morgan, Solicitor, K. Bacon, Barrister and E.S. Mackenzie, Solicitor)

Other parties to the proceedings: European Medicines Agency, European Commission

Form of order sought

The appellants claim that the Court should:

| — | Set aside the judgment of the General Court; |
| --- | --- |

—

Set aside the judgment of the General Court;

| — | Annul the decision of the EMA, contained in its letter of 24 January 2012, refusing to validate the appellant’s application for a marketing authorization; |
| --- | --- |

—

Annul the decision of the EMA, contained in its letter of 24 January 2012, refusing to validate the appellant’s application for a marketing authorization;

| — | Order the EMA to pay the costs of the Appellants. |
| --- | --- |

—

Order the EMA to pay the costs of the Appellants.

Pleas in law and main arguments

In support of the appeal, the appellants advance one ground of appeal, which is that the General Court erred in law in its interpretation of Article 8 of Regulation (EC) No 141/2000 (1). Three distinct errors of law are alleged. First, it is alleged that the General Court misinterpreted Article 8(3) read together with Article 8(1), in that it failed to appreciate that a second similar orphan product authorised under an Article 8(3) derogation cannot attract the reward of market exclusivity that is provided for the first orphan product under Article 8(1).

Second, it erred in concluding that its interpretation of Article 8 does not have the effect of extending the market exclusively attaching to the first product.

Third, the General Court incorrectly described and thus failed properly to address the appellant’s alternative case in respect of the original ground for annulment, which was that even if the second product did in principle benefit from its own period of market exclusivity, that exclusivity should not operate to exclude from the market a generic version of the first product.

The appellant requests that the Court of Justice give final judgment annulling the contested decision.

---

(1)  Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products OJ 2000 L 18, p. 1.

---
# C_2017144EN.01003702.xml

| 8.5.2017 | EN | Official Journal of the European Union | C 144/37 |
| --- | --- | --- | --- |

8.5.2017

EN

Official Journal of the European Union

C 144/37

---

Judgment of the General Court of 16 March 2017 — Capella v EUIPO — Abus (APUS)

(Case T-473/15) (1)

1

((EU trade mark - Opposition proceedings - Application for the EU word mark APUS - Earlier national word mark ABUS - Relative ground for refusal - Article 8(1)(b) of Regulation (EC) No 207/2009 - Likelihood of confusion - Successive restrictions of the trade mark application before the Board of Appeal - Article 43(1) of Regulation No 207/2009 - Competence of the Board of Appeal - Article 64(1) of Regulation No 207/2009 - Right to be heard - Article 75, second sentence, of Regulation No 207/2009 - Rule 13(3) of Regulation (EC) No 2868/95))

(2017/C 144/49)

Language of the case: German

Parties

Parties

Applicant: Capella EOOD (Sofia, Bulgaria) (represented by: F. Henkel, lawyer)

Applicant:

Defendant: European Union Intellectual Property Office (represented by: S. Hanne, Agent)

Defendant:

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Abus August Bremicker Söhne KG (Wetter, Germany) (represented by: G. Hallwachs, lawyer)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court:

Re:

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 2 June 2015 (Case R 117/2014-4), relating to opposition proceedings between Abus August Bremicker Söhne and Capella.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Annuls the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 2 June 2015 (Case R 117/2014-4); |
| --- | --- |

1.

Annuls the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 2 June 2015 (Case R 117/2014-4);

| 2. | Orders EUIPO, in addition to bearing its own costs, to pay those incurred by Capella EOOD; |
| --- | --- |

2.

Orders EUIPO, in addition to bearing its own costs, to pay those incurred by Capella EOOD;

| 3. | Declares that Abus August Bremicker Söhne KG is to bear its own costs. |
| --- | --- |

3.

Declares that Abus August Bremicker Söhne KG is to bear its own costs.

---

(1)  OJ C 328, 5.10.2015.

1

---
[ J

- 54

- 2022 ]

IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

IN RE: SENIOR HEALTH INSURANCE COMPANY OF PENNSYLVANIA (IN REHABILITATION)

APPEAL OF: THE SUPERINTENDENT OF INSURANCE OF THE STATE OF MAINE,

THE COMMISSIONER OF INSURANCE

OF THE COMMONWEALTH OF

MASSACHUSETTS AND THE

INSURANCE COMMISSIONER OF THE

STATE OF WASHINGTON :

:

:

:

:

:

:

:

:

:

:

: No. 71 MAP 2021

Appeal from the Order of the

Commonwealth Court at No. 1 SHP 2020 dated August 24, 2021

ARGUED: September 15, 2022

O RDER

PER CURIAM DECIDED: June 20, 2023

AND NOW, this 20 th day of June , 2023

, the Order of the Commonwealth Court is

AFFIRMED

.

Opinion s to follow.

The Late Chief Justice Baer did not participate in the decision of this matter.
No. 55452.

#### E. S. Ullman Allied Co., Inc. *v.*United States,

protest 161946-K (New York).

Opinion by

Cole, J.

The protest was dismissed.
**Certification of the Principal Executive OfficerPursuant to 15 U.S.C. 78m(a) or 78o(d)(Section 302 of the Sarbanes-Oxley Act of 2002)**

I, Glenn F. Tilton, the Chairman, President and Chief Executive Officerof United Air Lines, Inc. (the "Company"), certify that:(1)     I have reviewed this quarterly reporton Form 10-Q for the quarter ended March 31, 2004 of the Company; (2)     Based on my knowledge, this report does notcontain any untrue statement of a material fact or omit to state a materialfact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to theperiod covered by this report; (3)     Based on my knowledge, the financial statements,and other financial information included in this report, fairly presentin all material respects the financial condition, results of operationsand cash flows of the Company as of, and for, the periods presented inthis report; (4)     The Company's other certifying officer andI are responsible for establishing and maintaining disclosure controlsand procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))for the Company and we have: (a)   Designed such disclosure controls and procedures,or caused such disclosure controls and procedures to be designed underour supervision, to ensure that material information relating to the Company,including its consolidated subsidiaries, is made known to us by otherswithin those entities, particularly during the period in which this reportis being prepared; (b)     Evaluated the effectiveness of the Company'sdisclosure controls and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures, as ofthe end of the period covered by this report based on such evaluation;and (c)     Disclosed in this report any change in theCompany's internal control over financial reporting that occurred duringthe Company's most recent fiscal quarter that has materially affected,or is reasonably likely to materially affect, the Company's internal controlover financial reporting; and (5)     The Company's other certifying officer andI have disclosed, based on our most recent evaluation of internal controlover financial reporting, to the Company's auditors and the audit committeeof Company's board of directors (or persons performing the equivalent functions): (a)     All significant deficiencies and materialweaknesses in the design or operation of internal control over financialreporting which are reasonably likely to adversely affect the Company'sability to record, process, summarize and report financial information;and (b)     Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in the Company'sinternal control over financial reporting. /s/ Glenn F. TiltonGlenn F. TiltonUnited Air Lines, Inc.Chairman, President and Chief Executive OfficerApril 30, 2004
No. 71-7

#### John H. Jones, LCPL, U. S. Marine Corps v United States.

ORDERED;

That said Petition be, and the same is, hereby dismissed. This action is without prejudice to the right of petitioner to raise the issue therein presented should the same be considered necessary or advisable during the course of appellate review below and in a Petition for Grant of Review to this Court.
#### UNITED STATES, Appellee v DERRELL D. SMITH, Private First Class, U. S. Army, Appellant

19 USCMA 491, 42 CMR 93

*492No. 22,878

June 5, 1970

*Colonel Daniel T. Ghent, Captain Bernard J. Casey,*and *Captain Libero Marinetti, Jr.,*were on the pleadings for Appellant, Accused.

*Colonel David T. Bryant, Major Edwin P. Wasinger, Captain William R. Steinmetz,*and *Captain M. M. O’Dowd, Jr.,*were on the pleadings for Appellee, United States.

Opinion of the Court

DARDEN, Judge:

Evidence of an Article 15 disciplinary action for failing to obey an order to get a haircut was admissible against the appellant following his conviction for two aggravated assaults and carrying a concealed weapon, offenses occurring after August 1, 1969. United States v Johnson, 19 USCMA 464, 42 CMR 66 (1970); United States v Wheat, 19 USCMA 491, 42 CMR 93 (1970). Accordingly, the decision of the Court of Military Review is affirmed.

Chief Judge Quinn concurs.

Ferguson, Judge

(dissenting):

I dissent for the reasons set forth in my separate opinion in United States v Johnson, 19 USCMA 464, 42 CMR 66 (1970).
No. 56146.

protests 173768-K, etc. (New York).

#### Alfred A. Mazer et al. *v.*United States,

Opinion by

Ekwall, J.

In accordance with stipulation of counsel that the merchandise consists of live birds similar in all material respects to those the subject of *Alfred Mazer*v. *United States*(25 Cust. Ct. 67, C. D. 1265), the claim of the plaintiffs was sustained.